RxDoctor Payments Data

Julie Allen

Sleep Medicine · Searcy, ARNPI 1942619598

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,578 of the $4,392 with a category attached, or 81.5%. 22 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 31.2% of the total. 2025 is the largest year on record at $1,496, 2.1 times the $727 reported in 2021.

$4,392in general payments, 2019–2025

Across 160 payments — averaging $27.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$1K
  • Inspire Medical Systems, Inc.$802
  • Harmony Biosciences LLC$537
  • Boehringer Ingelheim$274
  • Axsome Therapeutics, Inc.$262
  • GSK$174
  • plus $972 from 16 others

What the payments were for

  • Travel & lodging$44610%
  • Food & beverage$3,57881%
  • Education$3678%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few sleep medicine providers in Arkansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$13,128
Medicare patients
171
Services billed
211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Spiriva HandihalerTiotropium Bromide11$5,963
Pramipexole DihydrochloridePramipexole Di-Hcl62$582
Pregabalin44$474
Prazosin Hcl29$460
Clonazepam19$269
Temazepam12$178
Montelukast Sodium11$152
Hydroxyzine Hcl22$124
Zaleplon11$112
Zolpidem Tartrate18$106
Alprazolam23$105
Diazepam14$39

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Searcy

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →